Event: Poster presentation: New Exploratory Alzheimer’s Drug ANAVEX 2-73: Dose Dependent
Clinical Cognitive Improvement Observed in Mini Mental State Examination (MMSE) and
Other Cognitive Markers in a Phase 2a Study in Mild-to-Moderate Alzheimer’s Patients
Date/Time: Sunday, July 24, 2016
9:30 a.m. to 10:30 a.m. EDT
Location: Hall D/E, Metro Toronto Convention Centre, Toronto, ON